- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
West Pharmaceutical's (WST) stock rating was slashed to 'market perform' at Wells Fargo on Wednesday.
Catalent and West Pharmaceutical Services provide products and services to biotech and pharmaceutical firms. Intellipharmaceutics is a small-cap firm on the rise.
Trade-Ideas LLC identified West Pharmaceutical Services (WST) as a strong and under the radar candidate
HRZN GHC WST are going ex-dividend Monday, Monday, July 18, 2016